Status:
COMPLETED
Managing Dry Eye in Patients Using Glaucoma Drops
Lead Sponsor:
He Eye Hospital
Conditions:
Dry Eye
Eligibility:
All Genders
18-99 years
Phase:
NA
Brief Summary
A single center randomized controlled trial on managing dry eye signs and symptoms in patients using anti-glaucoma eye drops.
Detailed Description
To compare the safety and efficacy of IPL therapy on drug-induced dry eye caused by long-term use of anti glaucoma drugs;
Eligibility Criteria
Inclusion
- Age ≥18 years
- Able and willing to comply with the treatment/follow-up schedule
- Bilateral signs and symptoms of dry eye disease
Exclusion
- Participants with systemic immune-mediated illnesses, such as secondary Sjögren's syndrome or graft-versus-host disease
- Patients using topical medication(s) for the treatment of ocular disorders such as allergic conjunctivitis were excluded from the study.
- Previous ocular surgery or trauma
- 1-month history of blepharal and periorbital skin disease or allergies
- Severe dry eyes with corneal epithelial defect
- Limbic keratitis
- Pterygium
- Corneal neovascularization
- Breastfeeding
- Rheumatic immune systemic diseases
- Herpes zoster infection
- Pregnant women
- Allergic to fluorescein
- Contact lens wearers
Key Trial Info
Start Date :
October 3 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 2 2023
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06158984
Start Date
October 3 2023
End Date
December 2 2023
Last Update
December 27 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
He Eye Hospital
Shenyang, Liaoning, China, 110001